Molecular Materials And Medicinal Molecules
The PT Lab focuses on the design and synthesis of boron-containing molecular materials and bioactive compounds, combining concepts from organic, organometallic, materials, and chemical biology. The group’s research aims to develop functional molecular systems with applications in optoelectronics, sensing, imaging, and medicine. Through interdisciplinary approaches, the lab explores how molecular design and structure influence photophysical behavior, reactivity, and biological activity.
A major theme of the group is the development of boron-based luminescent materials, including triaryl and aminoboranes and related chromophores that exhibit unique properties such as fluorescence, delayed emission, aggregation-induced emission, and room-temperature phosphorescence. These properties enable applications in OLED materials, molecular electronics, chemical sensors, and bioimaging probes. The lab also investigates stimuli-responsive photoluminescent systems and chiral molecular materials, which are relevant for advanced photonic technologies and security applications.
In parallel, the PT Lab is engaged in boron-based medicinal chemistry, including the development of boronopeptides and enzyme-targeting inhibitors/activators. These studies exploit the Lewis acidic nature of tricoordinate boron to interact with biological targets, offering opportunities for new therapeutic strategies. The group actively collaborates with biologists at IISc to investigate biological applications such as imaging and enzyme inhibition. In addition, the lab maintains international research collaborations, for advanced characterization and materials development.
The PT Lab welcomes motivated PhD students, postdoctoral researchers, and collaborators interested in interdisciplinary research at the interface of chemistry, materials science, and biology. The group is also open to industrial partnerships aimed at translating molecular discoveries into technologies for sensing, photonics, and biomedical applications. Interested researchers and organizations are encouraged to explore collaboration opportunities with the lab.
Representative Publications
-
Subhajit Ghosh, Rajendra Prasad Nandi, Shamil R, Yapamanu Adithya Lakshmanna, Silvano Geremia, Neal Hickey, Abhishek Sirohiwal and Pakkirisamy ThilagarNat. Commun. 17, 2936 (2026)DOI: 10.1038/s41467-026-69664-x
-
Nishant Dhiman, Potla Yedukondalu, Akkarakkaran Thayyil Muhammed Munthasir, Soumen Ghosh, Pakkirisamy Thilagar, Siva UmapathyJ. Phys. Chem. A 130, 2137 (2026)DOI: 10.1021/acs.jpca.5c08610
-
Poonam Rani, Nimisha Basavaraj, Reddy Peera Kommaddi, and Pakkirisamy ThilagarAlzheimer’s & Dementia 21, e098876 (2025)DOI: 10.1002/alz70859_098876
-
Sambit Pradhan, Surajit Sarker and Pakkirisamy ThilagarJ. Med. Chem. 67, 18794 (2024)DOI: 10.1021/acs.jmedchem.4c01113
-
J. Han, H. Xu, A. Sharma, J. Asatryan, F. Rauch, A. Friedrich, J. Krebs, L. Swoboda, J. Schuster, S. Pagidi, K. Neena; M. Alqurashi, P. Thilagar, N. Schopper, I. Krummenacher, V. Stepanenko, M. Finze, H. Braunschweig, J. Martin, F. Würthner, D. Baran, T. MarderJ. Am. Chem. Soc. 147, 28694 (2025)DOI: 10.1021/jacs.5c02308
-
Jusaina Eyyathiyil, Subhajit Ghosh, Arunima Cheran, Silvano Geremia, Jatish Kumar, Neal Hickey, Pakkirisamy ThilagarCommun. Chem. 8, 126 (2025DOI: 10.1038/s42004-025-01529-8
-
Satyam Jena, Jusaina Eyyathiyil, Santosh Kumar Behera, Maho Kitahara, Yoshitane Imai, and Pakkirisamy Thilagar,Chem. Sci. 13, 5893 (2022)DOI: 10.1039/D2SC00990K
-
Sanjoy Mukherjee and Pakkirisamy ThilagarAngew. Chem. Int. Ed. 58, 2 (2019)DOI: 10.1002/anie.201811542
-
Satyam Jena, Santosh Kumar Behera, Jusaina Eyyathiyil, Maho Kitahara, Yoshitane Imai, Pakkirisamy ThilagarAdv. Optical Mater. 11, 2300923 (2023)DOI: 10.1002/adom.202300923
-
Kalluvettukuzhy K. Neena, Pagidi Sudhakar and Pakkirisamy ThilagarAngew. Chem. Int. Ed. 57, 16806 (2018)DOI: 10.1002/anie.201811353